State Street Corp Foghorn Therapeutics Inc. Transaction History

State Street Corp

  • $2.8 Trillion
  • Q3 2025

A detailed history of State Street Corp transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 637,148 shares of FHTX stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
637,148
Previous 543,647 17.2%
Holding current value
$2.99 Million
Previous $2.56 Million 21.92%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$4.58 - $6.5 $428,234 - $607,756
93,501 Added 17.2%
637,148 $3.12 Million
Q2 2025

Aug 14, 2025
SELL
$3.15 - $4.9 $134,095 - $208,593
-42,570 Reduced 7.26%
543,647 $2.56 Million
Q1 2025

May 15, 2025
BUY
$3.52 - $6.16 $66,352 - $116,116
18,850 Added 3.32%
586,217 $2.14 Million
Q4 2024

Feb 14, 2025
BUY
$4.61 - $9.35 $283,155 - $574,295
61,422 Added 12.14%
567,367 $2.68 Million
Q3 2024

Nov 14, 2024
BUY
$4.8 - $9.99 $113,424 - $236,063
23,630 Added 4.9%
505,945 $4.71 Million
Q2 2024

Aug 14, 2024
BUY
$5.05 - $8.0 $225,487 - $357,208
44,651 Added 10.2%
482,315 $2.77 Million
Q1 2024

May 15, 2024
BUY
$2.82 - $7.94 $42,395 - $119,369
15,034 Added 3.56%
437,664 $2.94 Million
Q4 2023

Feb 14, 2024
SELL
$2.94 - $6.76 $33,045 - $75,982
-11,240 Reduced 2.59%
422,630 $2.73 Million
Q3 2023

Nov 14, 2023
SELL
$5.0 - $9.87 $26,985 - $53,268
-5,397 Reduced 1.23%
433,870 $2.17 Million
Q2 2023

Aug 14, 2023
BUY
$5.37 - $8.84 $159,778 - $263,025
29,754 Added 7.27%
439,267 $3.09 Million
Q1 2023

May 15, 2023
BUY
$4.66 - $8.99 $25,047 - $48,321
5,375 Added 1.33%
409,513 $2.54 Million
Q4 2022

Feb 14, 2023
BUY
$5.44 - $9.46 $176,908 - $307,639
32,520 Added 8.75%
404,138 $2.58 Million
Q3 2022

Nov 15, 2022
BUY
$7.52 - $18.01 $11,926 - $28,563
1,586 Added 0.43%
371,618 $3.19 Million
Q2 2022

Aug 15, 2022
BUY
$8.48 - $16.84 $439,323 - $872,429
51,807 Added 16.28%
370,032 $5.03 Million
Q1 2022

May 16, 2022
BUY
$8.87 - $22.1 $138,824 - $345,887
15,651 Added 5.17%
318,225 $4.85 Million
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $836,807 - $1.77 Million
77,554 Added 34.47%
302,574 $6.92 Million
Q3 2021

Nov 15, 2021
BUY
$8.33 - $15.02 $296,722 - $535,027
35,621 Added 18.81%
225,020 $3.14 Million
Q2 2021

Aug 16, 2021
BUY
$9.32 - $13.26 $748,396 - $1.06 Million
80,300 Added 73.6%
189,399 $2.02 Million
Q1 2021

May 17, 2021
BUY
$11.8 - $23.11 $86,175 - $168,772
7,303 Added 7.17%
109,099 $1.44 Million
Q4 2020

Feb 16, 2021
BUY
$15.12 - $25.88 $1.54 Million - $2.63 Million
101,796 New
101,796 $2.06 Million

Others Institutions Holding FHTX

# of Institutions
88
Shares Held
37M
Call Options Held
100
Put Options Held
0
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $195M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email